Literature DB >> 3535720

Lysis-centrifugation blood culture technique. Clinical impact in Staphylococcus aureus bacteremia.

R C Walker, N K Henry, J A Washington, R L Thompson.   

Abstract

To determine the clinical impact of enhanced detection of Staphylococcus aureus by a lysis-centrifugation (LC) blood culture system, consecutive cases of S aureus bacteremia during a seven-month period were reviewed. Of 77 clinically significant cases, the LC system detected 70 cases (91%) while a conventional broth system detected 67 cases (87%). Of 60 cases detected by both systems, the LC system was positive earlier than the broth system by one or more days in 34 cases (57%) and later in none. It also detected more (12 vs four of 13) patients with persistent bacteremia who were receiving antimicrobial treatment. Forty-three patients (56%) did not receive appropriate antimicrobial therapy until cultures were reported positive. Enhanced detection of S aureus bacteremia is a clinically important advantage of the LC blood culture technique.

Entities:  

Mesh:

Year:  1986        PMID: 3535720

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  4 in total

1.  Effect of delay in processing on lysis-centrifugation blood culture results from marrow transplant patients.

Authors:  D J Hamilton; D Amos; R W Schwartz; C M Dent; G W Counts
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

Review 2.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

3.  Controlled clinical comparison of Isolator and BACTEC 9240 Aerobic/F resin bottle for detection of bloodstream infections.

Authors:  J K Pohlman; B A Kirkley; K A Easley; J A Washington
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

Review 4.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.